Sandip Kapadia, Director at Passage BIO, Inc. (PASG), sold 5,000 shares at $1.19 ($6K) on 2022-12-01, disclosed to the SEC on 2022-12-02.
Scheduled sale ($6k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| HRMY | SELL | 2025-12-09 | $791K | — | Filing → |
| HRMY | SELL | 2025-11-25 | $120K | — | Filing → |
| HRMY | SELL | 2025-08-19 | $1.6M | — | Filing → |